Liarozole
CAS No. 115575-11-6
Liarozole ( R75251 dihydrochloride )
Catalog No. M23335 CAS No. 115575-11-6
Liarozole is a cytochrome P450 (CYP450) dependent inhibitor, orally active, it also a potent inhibitor of estrogen (via inhibition of aromatase) and testicular androgen synthesis (inhibition of 17 ,20-lyase).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 178 | In Stock |
|
10MG | 295 | In Stock |
|
25MG | 502 | In Stock |
|
50MG | 709 | In Stock |
|
100MG | 1008 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLiarozole
-
NoteResearch use only, not for human use.
-
Brief DescriptionLiarozole is a cytochrome P450 (CYP450) dependent inhibitor, orally active, it also a potent inhibitor of estrogen (via inhibition of aromatase) and testicular androgen synthesis (inhibition of 17 ,20-lyase).
-
DescriptionLiarozole is a cytochrome P450 (CYP450) dependent inhibitor, orally active, it also a potent inhibitor of estrogen (via inhibition of aromatase) and testicular androgen synthesis (inhibition of 17 ,20-lyase).Liarozole dihydrochloride is an imidazole derivative;?it is being investigated as a non-hormonal agent in prostate cancer and in the treatment of various other cancers and skin disorders.?
-
SynonymsR75251 dihydrochloride
-
PathwayMetabolic Enzyme/Protease
-
TargetP450
-
RecptorCYP450
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number115575-11-6
-
Formula Weight308.8
-
Molecular FormulaC17H13ClN4
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESClC1=CC(C(C2=CC=C3NC=NC3=C2)N4C=CN=C4)=CC=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bryson HM, et al. Liarozole. Drugs Aging. 1996 Dec;9(6):478-84; discussion 485.
molnova catalog
related products
-
Verapamil
Verapamil is a calcium channel blocker and an orally active and effective inhibitor of P-gp.
-
Ambroxol
Ambroxol is indicated as "secretolytic therapy in bronchopulmonary diseases associated with abnormal mucus secretion and impaired mucus transport.
-
1-Ethynylpyrene
1-Ethynylpyrene is an aryl acetylenic inhibitor of CYTP450 1A1(IC50=0.18 μM), 1A2(IC50 = 0.32 μM), and 2B1(IC50 = 0.04 μM).